Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to our new ARUK Clinical Research Fellows, Dr Malvika Gulati and Miss Jennifer Lane on their successful Fellowship applications.

Jennifer will be studying the “Epidemiology of common hand conditions”. The project will study trends in disease variation and the surgical management of the condition at a national level using routinely collected UK GP and hospital data. Two large research studies, UK Biobank and the Million Women Study, will also be used to study over 1.8 million people to consider risk factors in developing severe osteoarthritis.

Commenting on the news of her successful application Jennifer stated “I'm thrilled to be working with ARUK for this project that I hope will help us better understand why people develop hand conditions, and aid us in determining the best surgical treatments for the future."

Jennifer will be sponsored by Prof Dominic FurnissProf Daniel Prieto-Alhambra and Prof Jane Green at the Million Women Study based in the Cancer Epidemiology Unit at the Nuffield Department of Population Health.

Dr Malvika Gulati will be looking at ”The role of gender, menopause and sex hormones in painful hand osteoarthritis (OA)”. Hand OA is common, affecting 2 million people in the UK and can cause pain, swelling and deformity and has greater occurrences in women. The project aims to improve understanding of the role of gender and hormonal influences in the pathogenesis of painful hand OA, in order to predict individual outcomes and identify new treatment strategies.

On acceptance of the award Malvika stated "I am grateful for the opportunity that Arthritis Research UK has given us. Hand osteoarthritis is the most common form of arthritis in the hand, yet treatment options are limited. This funding will allow us to better understand the condition and test our hypothesis that hormones may play a role in its development.”  

Malvika will be sponsored by Prof Fiona WattProf Tonia Vincent and Prof Nigel Arden.

FUNDING BODY

New funding for arthritis research

Similar stories

The Kennedy Institute completes its roof extension

Building work at the Kennedy Institute of Rheumatology has finished, providing a new third floor that houses additional meeting and collaboration space for data science and offices for the management of clinical trials.

Neutrophil molecular wiring revealed: transcriptional blueprint of short-lived cells

Researchers publish the first blueprint of transcriptional factors that control neutrophil-driven inflammation in Nature Immunology.

Exploring the link between joint injury and osteoarthritis

A new study published in The Lancet Rheumatology shows potential ways to predict how likely someone is to develop osteoarthritis after a knee injury.

EPSRC funds research to avert an antibiotics apocalypse

Researchers at the Kennedy Institute join a collaboration to find new ‘drug-free’ ways of treating illnesses where current treatments have become ineffective due to antibiotic resistance.

Repurposed drug can induce remission of inflammatory arthritis

Researchers at the Kennedy Institute demonstrate that the drug decitabine can boost regulatory T cell responses.

Major ERC funding awarded to Professor Michael Dustin

Professor Michael Dustin and an international team of collaborators have been awarded a €10M grant from the European Research Council (ERC) to develop a new biotechnology around supramolecular attack particles (SMAPs) engineered to kill cancer cells.